Mode
Text Size
Log in / Sign up
N/A N=55 Treatment

Virtual Empowered Relief for Chronic Pain

Chronic Pain · Pain

Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Perceived Usefulness — 8.25 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Empowered Relief class (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Stanford University
Primary completion
Oct 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Perceived Usefulness
8.25
PRIMARY
Participant Satisfaction
8.59
PRIMARY
Likelihood of Using the Skills
8.47
SECONDARY
Pain Bothersomeness
5.9 <.001 sig
SECONDARY
PCS Total Scores
19.02 .208
SECONDARY
Pain Intensity
5.58 <.001 sig
SECONDARY
PROMIS-Sleep Disturbance
57.31 .328

Summary

The purpose of the current pilot study is to examine a feasibility and the preliminary efficacy of Empowered Relief (ER) class when it is delivered 'virtually' to patients with chronic pain who take methadone or buprenorphine. The ER class is a single-session pain management class, which has demonstrated to be effective in improving pain and pain-related distress in patients with chronic low back pain, but its efficacy has not been examined in patients with chronic pain who take methadone or buprenorphine. Class participants will learn self-regulatory skills and develop a personalized plan to use the skills every day. The current study will examine a feasibility and participant's perception and satisfaction of this class at post-class. The study will also follow participants 3 months by administering 5 surveys (baseline, 2 weeks and 1 month, 2 months, and 3 months post-treatment) to determine whether the class confers the short-term and medium-term benefits across various aspects of health.

Eligibility Criteria

Inclusion Criteria

  • Age at least 18 years old
  • Chronic Pain (> 3 months)
  • Taking Methadone or Buprenorphine
  • English Fluency

Exclusion Criteria

  • Pregnant,
  • Gross Cognitive Impairment,
  • Acute Suicidality,
  • Severe Depression
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05057988). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search